| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1995PNAS...92.3586H |
| P356 | DOI | 10.1073/PNAS.92.8.3586 |
| P932 | PMC publication ID | 42212 |
| P698 | PubMed publication ID | 7724603 |
| P5875 | ResearchGate publication ID | 15473791 |
| P50 | author | H. Eugene Stanley | Q870027 |
| Shlomo Havlin | Q1632961 | ||
| Sergey V. Buldyrev | Q48446569 | ||
| P2093 | author name string | R N Mantegna | |
| G W Rebeck | |||
| B T Hyman | |||
| H L West | |||
| M Ukleja | |||
| P2860 | cites work | Apolipoprotein E polymorphism and Alzheimer's disease. | Q53316388 |
| Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB | Q54131245 | ||
| Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms | Q69028231 | ||
| Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions | Q70478363 | ||
| Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid | Q70687889 | ||
| Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14 | Q28156208 | ||
| Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease | Q28241772 | ||
| Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid | Q28279517 | ||
| The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease | Q29614948 | ||
| Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease | Q29614952 | ||
| Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease | Q29617286 | ||
| Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids | Q34255552 | ||
| Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production | Q34280406 | ||
| Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease | Q34662682 | ||
| Amyloid, dementia and Alzheimer's disease | Q36289653 | ||
| On 1/f noise and other distributions with long tails | Q36297394 | ||
| Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease | Q36604545 | ||
| The pathological association between Down syndrome and Alzheimer disease | Q39486734 | ||
| Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? | Q40918121 | ||
| Production of the Alzheimer amyloid beta protein by normal proteolytic processing | Q41599298 | ||
| Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease | Q41644400 | ||
| The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease | Q42470207 | ||
| Alzheimer's disease: size class frequency distribution of senile plaques: do they indicate when a brain tissue was affected? | Q45226593 | ||
| Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs | Q46028454 | ||
| Serial reconstruction of β-protein amyloid plaques: relationship to microvessels and size distribution | Q47405365 | ||
| An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. | Q53207278 | ||
| The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. | Q53207598 | ||
| Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. | Q53209417 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 3586-3590 | |
| P577 | publication date | 1995-04-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). | |
| P478 | volume | 92 |
| Q48790396 | A beta deposition inhibitor screen using synthetic amyloid |
| Q26798983 | A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome |
| Q89575981 | APOE-amyloid interaction: Therapeutic targets |
| Q35660968 | APOEε2 is associated with milder clinical and pathological Alzheimer disease |
| Q24653813 | Aggregation and disaggregation of senile plaques in Alzheimer disease |
| Q48846819 | Allele varepsilon4 of apolipoprotein E gene is less frequent in Down syndrome patient of the Sicilian population and has no influence on the grade of mental retardation |
| Q48974769 | Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease. |
| Q34461295 | Alzheimer diseases: a model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases |
| Q53199617 | Alzheimer's amyloid of another flavour. |
| Q41074945 | Amyloid beta-protein and the genetics of Alzheimer's disease |
| Q37182136 | Anti-LRP/LR specific antibody IgG1-iS18 and knock-down of LRP/LR by shRNAs rescue cells from Aβ42 induced cytotoxicity |
| Q43986284 | Apolipoprotein E affects amyloid formation but not amyloid growth in vitro: mechanistic implications for apoE4 enhanced amyloid burden and risk for Alzheimer's disease |
| Q49016361 | Apolipoprotein E allele distribution in parents of Down's syndrome children |
| Q71828931 | Apolipoprotein E allele frequencies in sporadic inclusion body myositis |
| Q48898761 | Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's disease |
| Q45054674 | Apolipoprotein E genotype and lifetime cognitive decline. |
| Q37846932 | Apolipoprotein E in Alzheimer's disease and other neurological disorders |
| Q36784564 | Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease |
| Q72007219 | Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy |
| Q34688023 | Apolipoproteins and aging: emerging mechanisms |
| Q97533441 | Assessment of plaque morphology in Alzheimer's mouse cerebellum using three-dimensional X-ray phase-based virtual histology |
| Q48325860 | Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's disease. |
| Q33998681 | Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo |
| Q33292558 | Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life |
| Q39579845 | Biostatistical analysis of quantitative immunofluorescence microscopy images. |
| Q42045406 | Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice |
| Q35764103 | Cerebral lipid deposition in aged apolipoprotein-E-deficient mice |
| Q40983058 | Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology |
| Q30435267 | Cytoskeletal pathologies of Alzheimer disease |
| Q55364689 | Deciphering the Astrocyte Reaction in Alzheimer's Disease. |
| Q33494855 | Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease |
| Q38865366 | Dementia in Down's syndrome |
| Q36867708 | Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease |
| Q36853246 | Distribution of apolipoprotein E in senile plaques in brains with Alzheimer's disease: investigation with the confocal laser scan microscope |
| Q48260981 | Do beta-amyloid (Abeta) deposits in patients with Alzheimer's disease and Down's syndrome grow according to the log-normal model? |
| Q53352162 | Dynamic feedback in an aggregation-disaggregation model. |
| Q34169919 | Dynamics of plaque formation in Alzheimer's disease |
| Q46073648 | Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome |
| Q52138111 | Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome. |
| Q48829183 | Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease |
| Q51945354 | Exploring a mathematical model for the kinetics of beta-amyloid molecular imaging probes through a critical analysis of plaque pathology. |
| Q47307409 | Factors Determining the Size Frequency Distribution of β-Amyloid (Aβ) Deposits in Alzheimer's Disease |
| Q34063772 | Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo |
| Q50661663 | Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease. |
| Q34644025 | Genetic analysis of contributions of dorsal group and JAK-Stat92E pathway genes to larval hemocyte concentration and the egg encapsulation response in Drosophila |
| Q41099932 | Genetic analysis of mechanisms of aging |
| Q30978328 | Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy. |
| Q41877570 | Homocysteine and related genetic polymorphisms in Down's syndrome IQ. |
| Q37085952 | Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B |
| Q22001055 | In vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques. |
| Q47830185 | Inhibition of amyloid formation: a strategy to delay the onset of Alzheimer's disease. |
| Q30476008 | Interactions dominate the dynamics of visual cognition. |
| Q48404445 | Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. |
| Q48396205 | La lunga attesa: towards a molecular approach to neuroimaging and therapeutics in Alzheimer's disease |
| Q37148174 | Label-free optical quantification of structural alterations in Alzheimer's disease |
| Q48601482 | Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition |
| Q37558841 | Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate. |
| Q48336501 | Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele |
| Q60075531 | Missense on the membrane |
| Q44251907 | Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation. |
| Q41136726 | Molecular genetic advances in neurodegenerative disorders. |
| Q38993138 | Mouse-based genetic modeling and analysis of Down syndrome |
| Q53215966 | NIA/AIzA Conference on apolipoprotein E genotyping in Alzheimer's disease. Bibliography. |
| Q36353123 | Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia |
| Q53137703 | Neuropathology of Alzheimer's disease. |
| Q34391393 | Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease |
| Q38023860 | Neurotoxicity of amyloid β-protein: synaptic and network dysfunction |
| Q37731494 | On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants |
| Q36279313 | Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease |
| Q35032948 | Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controls |
| Q77227270 | Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology |
| Q33708963 | Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease |
| Q33564874 | Quantification of amyloid precursor protein isoforms using quantification concatamer internal standard |
| Q35689983 | Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease |
| Q39709721 | Resolving controversies on the path to Alzheimer's therapeutics |
| Q34509759 | Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy |
| Q52204282 | Scopolamine-induced impairment as a potential predictor of Alzheimer's disease in individuals with Apolipoprotein E type 4 alleles. |
| Q46399433 | Size frequency distribution of prion protein (PrP) aggregates in variant Creutzfeldt-Jakob disease (vCJD). |
| Q33604063 | Size frequency distribution of the beta-amyloid (abeta) deposits in dementia with Lewy bodies with associated Alzheimer's disease pathology |
| Q41997192 | Spectroscopic imaging with spectral domain visible light optical coherence microscopy in Alzheimer's disease brain samples. |
| Q36123958 | Stable size distribution of amyloid plaques over the course of Alzheimer disease |
| Q36897604 | The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease |
| Q21202840 | The generation and function of soluble apoE receptors in the CNS |
| Q48146435 | The role of −850 tumor necrosis factor-α and apolipoprotein E genetic polymorphism in patients with Down's syndrome-related dementia |
| Q53323913 | The use of apolipoprotein E genotyping as a diagnostic test in suspected Alzheimer's disease. |
Search more.